|
SYNJ1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82309999985364E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.077000E-03 |
| Normal-vs-Stage2 |
2.638400E-02 |
| Normal-vs-Stage3 |
2.57599999997637E-07 |
| Normal-vs-Stage4 |
6.94969637393683E-11 |
| Stage1-vs-Stage2 |
4.799600E-01 |
| Stage1-vs-Stage3 |
1.482330E-02 |
| Stage1-vs-Stage4 |
3.56409999999752E-05 |
| Stage2-vs-Stage3 |
4.574200E-01 |
| Stage2-vs-Stage4 |
7.454200E-02 |
| Stage3-vs-Stage4 |
9.369900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.46479999930361E-08 |
| Normal-vs-AfricanAmerican |
4.368000E-02 |
| Normal-vs-Asian |
7.710400E-01 |
| Caucasian-vs-AfricanAmerican |
7.262600E-01 |
| Caucasian-vs-Asian |
9.234000E-02 |
| AfricanAmerican-vs-Asian |
2.956200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.9682999997126E-08 |
| Normal-vs-Female |
1.076010E-03 |
| Male-vs-Female |
1.258970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.402600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.388100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.48670003980089E-09 |
| Normal-vs-Age(81-100Yrs) |
8.424500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.551400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.210600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.454400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.696200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.630400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.223800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.073000E-01 |
| Normal-vs-Grade 2 |
2.513800E-02 |
| Normal-vs-Grade 3 |
1.22690000381454E-08 |
| Normal-vs-Grade 4 |
1.63669078290241E-12 |
| Grade 1-vs-Grade 2 |
1.599550E-01 |
| Grade 1-vs-Grade 3 |
3.979800E-02 |
| Grade 1-vs-Grade 4 |
4.022600E-03 |
| Grade 2-vs-Grade 3 |
3.084800E-03 |
| Grade 2-vs-Grade 4 |
3.97989996514525E-09 |
| Grade 3-vs-Grade 4 |
1.762050E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.820400E-01 |
| Normal-vs-ccB subtype |
9.89610005053265E-09 |
| ccA subtype-vs-ccB subtype |
1.91110000002936E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.76719999999931E-05 |
| Normal-vs-N1 |
7.55680000000813E-05 |
| N0-vs-N1 |
2.263200E-01 |
|
|
